ANTI-PHOPHATIDYL SERINE AND ANTI-PROTHROMBIN ANTIBODIES (APS/PT) INIMMUNE THROMBOCYTOPENIA: SPACE FOR A MISDIAGNOSED ANDUNDERSTIMATED FORM OF SECONDARY ITP?

EHA Library, Sofia Camerlo, 422121

COMPREHENSIVE CHARACTERIZATION OF HEMATOLOGICAL ALTERATIONS IN FAMILIAL SITOSTEROLEMIA

EHA Library, Miguel Oliveira, 422122

PREDICTION OF STEROID RESPONSE IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA BY EVALUATING CD20+ B CELLS IN THE BONE MARROW

EHA Library, Yosuke DOMON, 422123

DOES ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBULIN IN COMBINATION WITH RITUXIMAB REDUCE ITS RESPONSE IN IMMUNE THROMBOCYTOPENIA?

EHA Library, Sylvain Audia, 422124

CHARACTERISTICS OF PATIENTS WITH CYCLIC THROMBOCYTOPENIA: AN INTERNATIONAL REGISTRY STUDY

EHA Library, Lisbeth Eischer, 422125

TREATMENT OF CRITICAL BLEEDS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW

EHA Library, Saifur Chowdhury, 422126

PREDICTION OF IMMUNE THROMBOCYTOPENIA PROGRESSIONBASED ON GLYCOCALICIN TEST DATA

EHA Library, Moldir Beshimbayeva, 422127

PHASE 4 STUDY RESULTS EVALUATING THE SAFETY, EFFICACY, AND TREATMENT SATISFACTION IN CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM

EHA Library, Scott Kolodny, 422128

SIALIC ACID LOSS IN PLATELETS: IMPLICATIONS IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Yessenia Lizbeth Molina Cabrera, 422129

CD8+CD25+ TREGS AS A PREDICTOR FOR GLUCOCORTICOID SENSITIVITY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Sara El-sayed, 422131

EVANS SYNDROME IN CROATIA – DATA FROM THE WORKING GROUP FOR BENIGN HEMATOLOGICAL DISEASES OF THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES KROHEM

EHA Library, Zdravko Mitrovic, 422132

A MULTI-COHORT STUDY ON THE HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Paul Coppo, 422133

TREATMENT OUTCOMES OF TPO-RECEPTOR AGONISTS IN PATIENTS WITH STEROID-REFRACTORY IMMUNE THROMBOCYTOPENIA; CONDITIONS FOR DISCONTINUATION WITH SUSTAINED PLATELET RESPONSE

EHA Library, JAE HO YOON, 422134

SPLEEN MICROBIOTA DYSBIOSIS PLAY A ROLE IN RESPONSE TO SPLENECTOMY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY

EHA Library, Jia Chen, 422135

FUNCTIONAL CHARACTERIZATION OF A NANOBODY BASED GPVI SPECIFIC PLATELET AGONIST

EHA Library, Minka Zivkovic, 422136

BASIC CHARACTERISTICS OF ADULT PATIENTS WITH PREVIOUSLY TREATED IMMUNE THROMBOCYTOPENIA ENROLLED IN LUNA 3 PHASE 3 PLACEBO-CONTROLLED STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR

EHA Library, David Kuter, 422137

REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY: DISTRICT GENERAL HOSPITAL EXPERIENCE IN MANAGING CLINICAL AND BIO-PSYCHO-SOCIAL COMPLEXITIES RELATED TO THROMBOPOIETIN RECEPTOR AGONISTS

EHA Library, Diana Mihalca, 422138

LONG-TERM SAFETY OUTCOMES OF ELIGLUSTAT IN PATIENTS WITH GAUCHER DISEASE: PROSPECTIVE, MULTICENTER, OBSERVATIONAL, POST AUTHORIZATION SAFETY SUB-REGISTRY STUDY

EHA Library, Pilar Giraldo, 422139

STEROIDS VS ELTROMBOPAG FOR FIRST AND SECOND-LINE TREATMENT OF ADULT IMMUNE THROMBOCYTOPENIA

EHA Library, Carlos Martínez Murillo, 422140

TREATMENTS FOR IMMUNE THROMBOCYTOPENIA (ITP) PLACE A BURDEN ON PATIENTS AND IMPACT QUALITY OF LIFE (QOL): INSIGHTS FROM A SOCIAL MEDIA LISTENING EXERCISE

EHA Library, Caroline Kruse, 422142

THROMBOCYTOPENIA IN PREGNANCY : A DESCRIPTIVE STUDY AND MANAGEMENT OF GESTATIONAL THROMBOCYTOPENIA AND IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

EHA Library, Ines Ben Rekaya, 422143

SELECTION AND EFFICACY OF DIFFERENT TREATMENTS FOR ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A CHINESE MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Jian Huang, 422144

THE ALTERNATIVE SPLICING OF LCK IN TREG INDUCTION IN IMMUNE THROMBOCYTOPENIA

EHA Library, Shaoqiu Leng, 422145

TREATMENT AND COMPLICATIONS OF PORTAL VEIN THROMBOSIS: HOW, HOW MUCH, AND FOR WHOM?

EHA Library, Mónica Fernández Pérez, 422146

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN CARRIERS OF PROTHROMBIN G20210A MUTATION

EHA Library, Carlos Aguilar Franco, 422147

GENETIC ASSOCIATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI:RS7586970 VARIANT) WITH CIRCULATING TISSUE FACTOR PATHWAY INHIBITOR LEVELS AND ISCHEMIC CORONARY ARTERY DISEASE

EHA Library, Doha Abdelhamid, 422148

APPROACH TO THE TREATMENT OF SUPERFICIAL THROMBOPHLEBITIS IN PREGNANCY – DATA FROM A PHYSICIAN SURVEY

EHA Library, Sajida Kazi, 422149

CLINICAL CHARACTERISTICS AND OUTCOMES OF YOUNG PATIENTS WITH THROMBOTIC MICROANGIOPATHY AT AIN-SHAMS UNIVERSITY CHILDREN’S HOSPITAL

EHA Library, Sara Makkeyah, 422150

PECTORAL MUSCLE LOSS  IS ASSOCIATED WITH ELEVATED FIBRINOLYTIC SYSTEM COMPONENTS IN COVID-19

EHA Library, Taner Tan, 422151

PREVALENCE AND VENOUS THROMBOTIC RISK OF ARG67STOP POLYMORPHISM IN THE PROTEIN Z-DEPENDENT PROTEASE INHIBITOR

EHA Library, Nuria Bermejo, 422152

VON WILLEBRAND FACTOR (VWF) AS A BIOMARKER OF SEVERITY IN INFECTION: THE CASE OF THE COVID-19 DISEASE

EHA Library, Panagiota Tsiatsiou, 422153

PHLEGMASIA CERULEA DOLENS IN A PATIENT WITH MAY THURNER SYNDROME – A CASE REPORT

EHA Library, Joana Ribeiro, 422154

USAGE PATTERN OF ANTICOAGULANTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES RECEIVING ANTICANCER THERAPIES IN EU4 + UK.

EHA Library, Magdalena Ruiz, 422155

ATYPICAL PRESENTATIONS OF PEDIATRIC ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Assaf Barg, 422156

A COMPARATIVE ANALYSIS OF CONCENTRATIONS OF DIRECT ORAL ANTICOAGULANTS USING TWO ANTI-XA REAGENTS: DOAC LEVELS IN PATIENTS PLASMA

EHA Library, Sun Hack Lee, 422157

NATURAL ANTICOAGULANTS AND COMPLETE BLOOD COUNT INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

EHA Library, Ahmed Almenshawy, 422158

EFFICACY AND SAFETY OF RIVAROXABAN USE IN GREEK CHILDREN : A SINGLE REFERENCE CENTRE OBSERVATIONAL STUDY

EHA Library, AIKATERINI MICHALOPOULOU, 422159

EXPERT-LED CASE-BASED EDUCATION IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA INCREASES COMPETENCE IN IMPROVING LONG-TERM OUTCOMES

EHA Library, S Christy Rohani-Montez, 422160

CEREBRAL VEIN THROMBOSIS

EHA Library, Turki Alshuaibi, 422161

YOUNG AND HEALTHY, BUT NOT IMMUNE: A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Pedro Lupi, 422162

HEMOSTASIS-MODULATING EFFECT OF TUMOR MICROENVIRONMENT FACTORS ON THE BLOOD CIRCULATORY BED OF ONCOHEMATOLOGICAL PATIENTS

EHA Library, Vira Barilka, 422163

DESCRIPTION OF A SERIES OF CASES WITH PROTEIN S DEFICIENCY IN THE HEALTH AREA OF TOLEDO (SPAIN).

EHA Library, Ana Camacho Valencia, 422164

INDIRECT EVALUATION OF VASCULAR AND PLATELET HEMOSTASIS IN PATIENTS WITH UNSTABLE ANGINA IN EMERGENCY SETTINGS

EHA Library, Yuliya Tyravska, 422165

STUDY OF THE DEVELOPMENT AND IMPLICATION OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN VASCULAR COMPLICATIONS OF LYSOSOMAL DISEASES.

EHA Library, Irene Serrano-Gonzalo, 422167

THROMBOSIS IN COVID-19 PATIENTS

EHA Library, Turki Alshuaibi, 422168

DESCRIPTIVE ANALYSIS OF A SERIES OF CASES OF HOMOZYGOUS CARRIERS OF THE 46C>T POLYMORPHISM IN THE FACTOR XII GENE.

EHA Library, Karla Susana Calzadilla Román, 422169

ACTIVITY OF BLOOD PLASMA MICROPARTICLES IN PATIENTS WITH LOWER EXTREMITY VASCULAR DISEASE

EHA Library, Olesia Matvienko, 422170

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN WOMEN WITH EARLY RECURRENT MISCARRIAGE

EHA Library, Carlos Aguilar Franco, 422171

HEREDITARY ANGIOEDEMA: THE OPTIMISATION OF MOLECULAR STUDIES IN DIFFERENTIAL DIAGNOSTICS

EHA Library, Ivo Barreiros, 422172

PATIENT INTERVIEW–BASED CONTENT VALIDATION OF THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM VERSION 4.0 (MFSAF V4.0)

EHA Library, Heather Gelhorn, 422175

PHYSICAL ACTIVITY IN RELATION TO SYMPTOM DEVELOPMENT AMONG PATIENTS WITH HEMATOLOGICAL CANCER DURING THEIR FIRST HALF YEAR AFTER DIAGNOSIS

EHA Library, Simone Oerlemans, 422176

MULTIPLE MYELOMA SYMPTOMS RELEVANT TO PATIENTS AND LINKED TO DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW AND DELPHI PANEL

EHA Library, Martin Kortüm, 422177

QUALITY OF LIFE AFTER IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN CHINA: A CROSS-SECTIONAL, MULTI-CENTER SURVEY OF PATIENT REPORTED OUTCOME AND CAREGIVER REPORTED OUTCOME

EHA Library, JIA CHEN, 422178

THE EFFECTIVENESS OF SYNBIOTIC PREPARATION IN PATIENTS WITH NEWLY DIAGNOSED LYMPHOMAS

EHA Library, Mariia Voytko, 422179

BURDEN OF MULTIPLE MYELOMA IN WOMEN: COLOMBIA AND THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Sossa-Melo, 422180

A QUALITATIVE STUDY OF HEMATOLOGICAL CANCER PATIENTS’ HEALTH INFORMATION NEEDS IN KUWAIT

EHA Library, Fatima Khadadah, 422181

QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB TREATMENT IN A REAL-WORLD SETTING

EHA Library, Tatyana Ionova, 422183

UNDERSTANDING THE PATIENT EXPERIENCE IN NON-HODGKIN’S LYMPHOMA; A QUALITATIVE PATIENT INTERVIEW STUDY

EHA Library, Sophie Van Tomme, 422184

COMPARATIVE EVALUATION OF QUALITY OF LIFE IN HEMOPHILIA A PATIENTS UNDER PROPHYLAXIS: A 4-YEAR PERSPECTIVE

EHA Library, Nikolaos Kotsiou, 422185

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION CAUSED NO SIGNIFICANT PATIENT-REPORTED SHORTNESS OF BREATH: FINDINGS FROM THE CONPET STUDY

EHA Library, Lene Kongsgaard Nielsen, 422186

IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE  SYMPTOM BURDEN SCALE (ISBUS): PROTOCOL FOR THE DEVELOPMENT OF A NOVEL STANDARDIZED PATIENT REPORTED OUTCOME MEASURE

EHA Library, Philip Powell, 422187

LEUKEMIA BURDEN IN THE COLOMBIAN POPULATION AND ITS CONTEXT IN THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Sossa-Melo, 422188

DEVELOPMENT OF NUTRITIONAL SCREENING FOR ONCOLOGY OUTPATIENTS: NSOO-2024

EHA Library, Celso Arrais-Rodrigues, 422189

EFFECTS OF AN EXERCISE THERAPY ON PHYSICAL FUNCTIONING AND QUALITY OF LIFE DURING ADULT UMBILICAL CORD BLOOD TRANSPLANTATION: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Chengzhen Jia, 422190

BURNOUT AMONG PALLIATIVE CARE DOCTORS IN ONCO-HEMATOLOGY

EHA Library, rihab ben sghaier, 422191

STUDY ON THE EFFECT OF GUIZHI FULING DECOCTION ON CHEMOTHERAPY-RELATED PERIPHERAL NEUROPATHY BY REGULATING METTL3/LET-7/NGF AXIS

EHA Library, xing cui, 422192

NURSING CARE OF A LYMPHOMA PATIENT WITH COVID-19 INFECTION UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CAR-T TREATMENT

EHA Library, Liu Tingting, 422193

CLINICAL HEMATOLOGY CAREGIVING STAFF: WHAT IMPACT ON PERSONAL AND PROFESSIONAL LIFE?

EHA Library, kenza Darkaoui, 422194

FINANCIAL BURDEN OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN NORTH MACEDONIA IN THE ERA OF NOVEL IMMUNOTHERAPIES

EHA Library, Nevenka Ridova, 422195

SUSTAINED COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AGED 26 YEARS OR OLDER IN ITALY

EHA Library, Monia Marchetti, 422196

THE INFLUENCE OF SOCIOECONOMIC FACTORS ON MORTALITY IN ACUTE MYELOID LEUKEMIA - AN INDIAN PERSPECTIVE

EHA Library, Priscilla Nethala, 422197

HEALTH ECONOMIC IMPACT OF SECOND-LINE INTERVENTIONS OF DIFFUSE LARGE B-CELL LYMPHOMA FOR TRANSPLANT-INELIGIBLE PATIENTS IN GERMANY

EHA Library, Melina Sophie Kurte, 422198

INNOVATIVE LABEL-FREE LYMPHOMA DIAGNOSIS USING INFRARED SPECTROSCOPY AND MACHINE LEARNING ON TISSUE SECTIONS

EHA Library, Sander De Bruyne, 422199

COMMUNITY: A NOVEL R-TOOL FOR DIFFERENTIAL COMMUNICATION ANALYSIS IN HUMAN BONE MARROW SCRNASEQ DATA OF AML PATIENTS IN A CASE-CONTROL DESIGN

EHA Library, Muhammet Celik, 422200

RISK FACTORS FOR SURVIVAL AND A PREDICTIVE MODEL OF INFUSION-RELATED REACTION IN B-CELL LYMPHOMA PATIENTS RECEIVING OBINUTUZUMAB

EHA Library, Shijie Li, 422201

TOWARDS AUTOMATED CYTOMORPHOLOGY ANALYSIS IN BONE MARROW SAMPLES: ARTIFICIAL INTELLIGENCE CAN INCREASE THE PRECISION OF BLAST COUNT

EHA Library, Miguel Gomez, 422202

AI-BASED AUTOMATION OF BONE MARROW PLASMA CELL QUANTIFICATION: IMPLICATIONS OF REDUCING VARIABILITY FOR MULTIPLE MYELOMA DIAGNOSIS

EHA Library, Ana Mendoza, 422203

PHASE 3 STUDY RESULTS OF ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-VRD) VERSUS VRD FOR TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (IMROZ)

EHA Library, Thierry Facon, 422204

THE LANDSCAPE OF TP53 MUTATIONS AND THEIR PROGNOSTIC IMPACT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Consuelo Bertossi, 422205

FIRST RESULTS OF THE APOLLO TRIAL: A RANDOMIZED PHASE III STUDY TO COMPARE ATO COMBINED WITH ATRA VERSUS STANDARD AIDA REGIMEN FOR PATIENTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Uwe Platzbecker, 422206

ASCIMINIB (ASC) PROVIDES SUPERIOR EFFICACY AND EXCELLENT SAFETY AND TOLERABILITY VS TYROSINE KINASE INHIBITORS (TKI) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN THE PIVOTAL ASC4FIRST STUDY

EHA Library, Andreas Hochhaus, 422207

ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA

EHA Library, Ali Taher, 422208

OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE IN PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA WITH THE NOVEL AMINO ACID DEGRADER CYST(E)INASE

EHA Library, Richard Burt, 422209

BCL-XL INHIBITOR, NAVITOCLAX, ENHANCES THE EFFICACY OF INDUCTION CHEMOTHERAPY IN PRECLINICAL MODELS OF RELAPSED PAEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Mankaran Singh, 422210

MASTER ONCOGENE NOTCH1 CONFERS A VULNERABILITY TO FERROPTOSIS IN HEMATOLOGICAL CANCERS

EHA Library, Guillaume Andrieu, 422211

TRANSCRIPTIONAL REPROGRAMMING SHAPES ALL RESPONSE TO NECROPTOTIC CELL DEATH

EHA Library, Anna Saorin, 422212

NOVEL APPROACH FOR FERROPTOSIS INDUCTION AND OVERCOMING CHEMORESISTANCE IN B-ALL VIA TARGETING POLO-LIKE KINASE

EHA Library, Pawel Stachura, 422213

WU-CART-007, AN ALLOGENEIC CAR-T CELL TARGETING CD7, IS HIGHLY EFFECTIVE AGAINST RELAPSED/REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (T-ALL/LBL)

EHA Library, Ibrahim Aldoss, 422214

BLINATUMOMAB FOR FIRST LINE TREATMENT IN INTERMEDIATE AND HIGH RISK DOWN SYNDROME B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA: INITIAL FINDINGS FROM THE ALLTOGETHER1 DS TRIAL

EHA Library, Sujith Samarasinghe, 422215

BLINATUMOMAB AS CONSOLIDATION IN A PAEDIATRIC PROTOCOL LEADS TO HIGH RATES OF END-CONSOLIDATION MRD NEGATIVITY AND EXCELLENT OUTCOMES IN AYA ALL – FINAL RESULTS OF THE ALLG ALL09 "SUBLIME" STUDY

EHA Library, Matthew Greenwood, 422216

BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN ADULT B-ALL: A COMPARISON OF THE CONSECUTIVE HOVON-100 AND H-146 STUDIES

EHA Library, Anita Rijneveld, 422217

OBECABTAGENE AUTOLEUCEL IN ADULT RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA: SURVIVAL AND POTENTIAL IMPACT OF CAR-T CELL PERSISTENCE AND STEM CELL TRANSPLANTATION IN THE FELIX STUDY

EHA Library, Claire Roddie, 422218

PONATINIB VERSUS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ ACUTE LYMPHOBLASTIC LEUKEMIA IN THE PHASE 3 PHALLCON TRIAL: IN-DEPTH RESPONDER ANALYSIS

EHA Library, Jose-Maria Ribera, 422219

EARLY RESPONSE REFINES END OF INDUCTION MEASURABLE RESIDUAL DISEASE STRATIFICATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Ozcan Gulbey, 422220

VENETOCLAX IN COMBINATION WITH THE PEDIATRIC-INSPIRED REGIMEN FOR THE TREATMENT OF NEWLY DIAGNOSED ADULTS WITH PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A PHASE 1 STUDY WITH AN EXPANSION COHORT

EHA Library, Ibrahim Aldoss, 422221

COMPREHENSIVE NEXT GENERATION SEQUENCING-BASED PROFILING OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TR) REARRANGEMENTS IN ALL IDENTIFIES CLONAL EVOLUTION AND AGE-RELATED PATTERNS

EHA Library, Monika Brüggemann, 422222

IMMUNE RECONSTITUTION AFTER CD7 CAR-T CELL THERAPY FOR REFRACTORY /RELAPSED ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(R/R T-ALL/LBL)

EHA Library, Xian Zhang, 422223

PHARMACOLOGICAL INHIBITION OF METTL1 AS A NOVEL THERAPEUTIC STRATEGY AGAINST AML

EHA Library, Eliza Yankova, 422224

UNCOVERING THE POTENTIAL OF THE PA2G4-MYC AXIS AS A TARGET IN 3Q26 ACUTE MYELOID LEUKEMIA

EHA Library, Giovanni Roti, 422225

IDENTIFICATION OF FOUR LEUKEMIC STEM CELL TYPES REVEALS DISTINCT AND COMMON RESISTANCE MECHANISMS TO VENETOCLAX/HYPOMETHYLATING AGENTS AND CHEMOTHERAPY

EHA Library, Alexander Waclawiczek, 422226